T. Naas

An anti-virulence drug targeting the evolvability protein Mfd protects against infections with antimicrobial resistant ESKAPE pathogens

NM102 targets the Mfd protein to reduce bacterial evolvability and treat infections caused by antibiotic-resistant Gram-negative bacteria.

Comparative genomics of carbapenemase-producing Morganella spp.

This study characterizes a large collection of carbapenemase-producing Morganella isolates, revealing new species, intrinsic resistance mechanisms, and potential therapeutic options.

Carbapenem heteroresistance of KPC-producing Klebsiella pneumoniae results from tolerance, persistence and resistance.

The paper investigates carbapenem heteroresistance in KPC-producing Klebsiella pneumoniae, revealing that it arises from tolerance, persistence, and resistance mechanisms.

Specificities and commonalities of carbapenemase producing Escherichia coli isolated in France from 2012 to 2015.

This study characterizes the spread and genetic diversity of carbapenemase-producing Escherichia coli in France from 2012 to 2015, identifying dominant lineages and plasmid-mediated carbapenemase dissemination.

Rapid Detection of VanA/B-Producing Vancomycin-Resistant enterococci using Lateral Flow Immunoassay from colonies and blood culture

This paper evaluates a lateral flow immunoassay for rapid detection of VanB-producing vancomycin-resistant enterococci with 100% sensitivity and specificity.

Stepwise evolution and convergent recombination underlie the global dissemination of carbapenemase-producing Escherichia coli

The paper investigates the molecular epidemiology of carbapenemase-producing Escherichia coli, identifying key genetic factors and recombination events driving their global spread.